BioSyent to Present at 2022 Bloom Burton & Co. Healthcare Investor Conference
26. April 2022 16:30 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2022 Bloom Burton & Co....
BioSyent Announces Grant of Restricted Share Units
31. März 2022 16:55 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 31, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 56,957 Restricted...
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2021
09. März 2022 16:34 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 09, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and twelve months ended December 31, 2021. Key...
BioSyent Schedules Q4 and Full Year 2021 Earnings Release for March 9, 2022
03. März 2022 16:28 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 03, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended...
BioSyent Adopts Advance Notice By-law
11. Februar 2022 09:29 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Feb. 11, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that its Board of Directors has approved the adoption of an Advance...
BioSyent Announces Renewal of Normal Course Issuer Bid
13. Dezember 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 13, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
BioSyent Releases Q3 and YTD 2021 Financial Results
18. November 2021 17:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 18, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2021. Key...
BioSyent Schedules Q3 and YTD 2021 Earnings Release for November 18, 2021
10. November 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 10, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
BioSyent Announces Launch of New FeraMAX® Pd Powder 15
19. Oktober 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce the launch of FeraMAX® Pd Powder 15 by its subsidiary,...
BioSyent annonce le lancement du nouveau FeraMAX (MD) Pd Poudre 15
19. Oktober 2021 08:00 ET
|
BioSyent Inc.
MISSISSAUGA, Ontario, 19 oct. 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent »,« la Société », Bourse de croissance TSX : RX) a le plaisir d’annoncer le lancement de FeraMAXMD Pd Poudre 15 par...